Cancer surgery opioid risk under microscope

NCT ID NCT03888651

Ongoing Knowledge-focused Sponsor: M.D. Anderson Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tracks 125 head and neck cancer patients after surgery to see how many end up using opioid painkillers long-term. Researchers will also look at factors like symptom burden and risk of opioid misuse. The goal is to better understand who is most at risk and why.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors identify which patients are at higher risk for long-term opioid use after head and neck cancer surgery, leading to better pain management plans.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly change patient care. The results may not apply to all patients or hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck cancer head and neck carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEAD AND NECK CARCINOMA

Contacts and locations

Locations

M D Anderson Cancer Center

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.